BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27129955)

  • 1. Stakeholders' rationales for representing uncertainties of biotechnological research.
    Post S; Maier M
    Public Underst Sci; 2016 Nov; 25(8):944-960. PubMed ID: 27129955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Communicating science in public controversies: Strategic considerations of the German climate scientists.
    Post S
    Public Underst Sci; 2016 Jan; 25(1):61-70. PubMed ID: 24583579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions of risk from nanotechnologies and trust in stakeholders: a cross sectional study of public, academic, government and business attitudes.
    Capon A; Gillespie J; Rolfe M; Smith W
    BMC Public Health; 2015 Apr; 15():424. PubMed ID: 25928741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scientific evidence and mass media: Investigating the journalistic intention to represent scientific uncertainty.
    Guenther L; Ruhrmann G
    Public Underst Sci; 2016 Nov; 25(8):927-943. PubMed ID: 26802103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving biotechnology communication.
    Weitze MD; Pühler A;
    Biotechnol J; 2013 Sep; 8(9):970-2. PubMed ID: 23801558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safe and Sound? Scientists' Understandings of Public Engagement in Emerging Biotechnologies.
    Braun M; Starkbaum J; Dabrock P
    PLoS One; 2015; 10(12):e0145033. PubMed ID: 26660160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring the perceived uncertainty of scientific evidence and its relationship to engagement with science.
    Retzbach J; Otto L; Maier M
    Public Underst Sci; 2016 Aug; 25(6):638-55. PubMed ID: 25814513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Options for a rational dialogue on the acceptance of biotechnology.
    von Grebmer K; Omamo SW
    Biotechnol J; 2007 Sep; 2(9):1121-8. PubMed ID: 17703485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transparent communication strategy on GMOs: will it change public opinion?
    Sinemus K; Egelhofer M
    Biotechnol J; 2007 Sep; 2(9):1141-6. PubMed ID: 17703492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bringing scientists to the people--the Co-Extra website.
    Breyer D; Daubresse P; Sneyers M
    Biotechnol J; 2007 Sep; 2(9):1081-5. PubMed ID: 17703490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes to biotechnology: estimating the opinions of a better-informed public.
    Sturgis P; Cooper H; Fife-Schaw C
    New Genet Soc; 2005 Apr; 24(1):31-56. PubMed ID: 16552916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Journalism and science: how to erode the idea of knowledge.
    Meyer G
    J Agric Environ Ethics; 2006; 19(3):239-52. PubMed ID: 17061381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of trust in the general science and climate science research of US federal agencies.
    Myers TA; Kotcher J; Stenhouse N; Anderson AA; Maibach E; Beall L; Leiserowitz A
    Public Underst Sci; 2017 Oct; 26(7):843-860. PubMed ID: 26960910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The (co-)production of public uncertainty: UK scientific advice on mobile phone health risks.
    Stilgoe J
    Public Underst Sci; 2007 Jan; 16(1):45-61. PubMed ID: 17575708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scientific uncertainty in media content: Introduction to this special issue.
    Peters HP; Dunwoody S
    Public Underst Sci; 2016 Nov; 25(8):893-908. PubMed ID: 27856828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public perceptions of biotechnology.
    McHughen A
    Biotechnol J; 2007 Sep; 2(9):1105-11. PubMed ID: 17639530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The problems of increasing transparency on uncertainty.
    Osman M; Heath AJ; Löfstedt R
    Public Underst Sci; 2018 Feb; 27(2):131-138. PubMed ID: 28535719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scientific information and uncertainty: challenges for the use of science in policymaking.
    Ascher W
    Sci Eng Ethics; 2004 Jul; 10(3):437-55. PubMed ID: 15362701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Science in the Public Eye: Leveraging Partnerships-An Introduction.
    Merson M; Allen LC; Hristov NI
    Integr Comp Biol; 2018 Jul; 58(1):52-57. PubMed ID: 29939248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Talking biotech with the public.
    Brauerhoch FO; Ewen C; Sinemus K
    Biotechnol J; 2007 Sep; 2(9):1076-80. PubMed ID: 17703483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.